Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Titel:
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Auteur:
Gettinger, Scott N Bazhenova, Lyudmila A Langer, Corey J Salgia, Ravi Gold, Kathryn A Rosell, Rafael Shaw, Alice T Weiss, Glen J Tugnait, Meera Narasimhan, Narayana I Dorer, David J Kerstein, David Rivera, Victor M Clackson, Timothy Haluska, Frank G Camidge, David Ross